-
1.
公开(公告)号:JP2010024156A
公开(公告)日:2010-02-04
申请号:JP2008185042
申请日:2008-07-16
Applicant: Ucb Pharma Sa , ユセベ ファーマ,ソシエテ アノニム
Inventor: POULAIN CLAIRE , FANARA DOMENICO
IPC: A61K31/4015 , A61K9/10 , A61K47/10 , A61K47/32 , A61K47/42 , A61P7/04 , A61P9/06 , A61P9/10 , A61P11/02 , A61P11/04 , A61P11/06 , A61P21/02 , A61P25/00 , A61P25/02 , A61P25/04 , A61P25/06 , A61P25/08 , A61P25/10 , A61P25/12 , A61P25/14 , A61P25/16 , A61P25/22 , A61P25/24 , A61P25/36 , A61P37/08 , C07D207/27
CPC classification number: A61K9/0095 , A61K9/0056 , A61K9/1623 , A61K9/1635 , A61K31/4015
Abstract: PROBLEM TO BE SOLVED: To provide a pharmaceutical composition comprising levetiracetam, brivaracetam or seletracetam as an effective ingredient.
SOLUTION: The pharmaceutical composition is an orally administrable one in a dry syrup form and comprises levetiracetam, brivaracetam or seletracetam as an effective ingredient, and at least 10-90 wt.%, based on the total weight of the composition, of a granular diluent having an average particle size of 75-520 μm selected from among mannitol, sorbitol and xylitol as an excipient.
COPYRIGHT: (C)2010,JPO&INPITAbstract translation: 待解决的问题:提供一种药物组合物,其包含左乙拉西坦,四乙酰胺或塞曲西坦作为有效成分。 解决方案:药物组合物是干糖浆形式的可口服给药的组合物,其包含左乙拉西坦,布立西坦或塞曲坦作为有效成分,并且至少10-90重量%,基于组合物的总重量, 选自甘露醇,山梨醇和木糖醇作为赋形剂的平均粒度为75〜520μm的粒状稀释剂。 版权所有(C)2010,JPO&INPIT
-
2.
公开(公告)号:WO2008006528A3
公开(公告)日:2008-04-10
申请号:PCT/EP2007006054
申请日:2007-07-09
Applicant: UCB PHARMA SA , GOFFIN CAROLINE , BERWAER MONIQUE , BOONEN MICHAEL , DELEERS MICHEL , FANARA DOMENICO
Inventor: GOFFIN CAROLINE , BERWAER MONIQUE , BOONEN MICHAEL , DELEERS MICHEL , FANARA DOMENICO
IPC: A61K9/22 , A61K31/4015
CPC classification number: A61K9/2054 , A61K31/4015
Abstract: The present invention relates to a pharmaceutical composition comprising levetiracetam as active ingredient, the invention relates specifically to a prolonged release formulation.
Abstract translation: 本发明涉及包含左乙拉西坦作为活性成分的药物组合物,本发明具体涉及延长释放制剂。
-
公开(公告)号:CA2747396C
公开(公告)日:2015-12-08
申请号:CA2747396
申请日:2010-01-27
Applicant: UCB PHARMA SA
Inventor: CUYPERS SERGE , BERWAER MONIQUE , FANARA DOMENICO , BARILLARO VALERY , LARBANOIX MARTINE , DARGELAS FREDERIC
IPC: A61K9/20 , A61K31/4015
Abstract: The present invention relates to an immediate release formulation of pharmaceutical compounds.
-
公开(公告)号:CA2722093C
公开(公告)日:2015-04-28
申请号:CA2722093
申请日:2009-05-28
Applicant: UCB PHARMA SA
Inventor: EECKMAN FREDERIC , BERWAER MONIQUE , FANARA DOMENICO
Abstract: The present invention relates to a pharmaceutical composition comprising brivaracetam as active ingredient, the invention relates specifically to a prolonged release formulation.
-
公开(公告)号:RS53554B1
公开(公告)日:2015-02-27
申请号:RSP20140539
申请日:2010-01-27
Applicant: UCB PHARMA SA
Inventor: CUYPERS SERGE , BERWAER MONIQUE , FANARA DOMENICO , BARILLARO VALERY
IPC: A61K9/20 , A61K9/16 , A61K9/28 , A61K31/4015
Abstract: The present invention relates to an immediate release formulation of pharmaceutical compounds.
-
6.
公开(公告)号:EA019583B1
公开(公告)日:2014-04-30
申请号:EA201100753
申请日:2009-11-17
Applicant: UCB PHARMA SA
Inventor: FANARA DOMENICO , EECKMAN FREDERIC , BERWAER MONIQUE
IPC: A61K9/50 , A61K31/4015
Abstract: Впатентефармацевтическаякомпозиция, включающаяв качествеактивногоингредиентабриварацетамилиселетрацетам, атакжеболееподробнокомпозицияс пролонгированнымвысвобождением, котораяполученаизгранул, содержащихактивныйингредиентвовнутреннемядреуказаннойкомпозиции.
-
公开(公告)号:AU2010209790B2
公开(公告)日:2014-01-16
申请号:AU2010209790
申请日:2010-01-27
Applicant: UCB PHARMA SA
Inventor: CUYPERS SERGE , BERWAER MONIQUE , FANARA DOMENICO , BARILLARO VALERY , LARBANOIX MARTINE , DARGELAS FREDERIC
IPC: A61K9/20 , A61K31/4015
Abstract: The present invention relates to an immediate release formulation of pharmaceutical compounds.
-
公开(公告)号:EA018736B1
公开(公告)日:2013-10-30
申请号:EA201001402
申请日:2009-03-02
Applicant: UCB PHARMA SA
Inventor: SCHENKEL ERIC , POULAIN CLAIRE , DODELET BERTRAND , FANARA DOMENICO
IPC: A61K9/08 , A61K31/4015
Abstract: Визобретенииописанстабильныйфармацевтическийраствор, способегополученияи терапевтическогоприменения.
-
公开(公告)号:HK1148202A1
公开(公告)日:2011-09-02
申请号:HK11102314
申请日:2011-03-08
Applicant: UCB PHARMA SA
Inventor: SCHENKEL ERIC , POULAIN CLAIRE , DODELET BERTRAND , FANARA DOMENICO
IPC: A61K20060101
Abstract: The present invention concerns a stable pharmaceutical solution, a process of the preparation thereof and therapeutic uses thereof.
-
公开(公告)号:CA2747396A1
公开(公告)日:2010-08-05
申请号:CA2747396
申请日:2010-01-27
Applicant: UCB PHARMA SA
Inventor: CUYPERS SERGE , BERWAER MONIQUE , FANARA DOMENICO , BARILLARO VALERY , LARBANOIX MARTINE , DARGELAS FREDERIC
IPC: A61K9/20 , A61K31/4015
Abstract: The present invention relates to an immediate release formulation of pharmaceutical compounds.
-
-
-
-
-
-
-
-
-